2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CURRENT PHARMACEUTICAL DESIGN CURR PHARM DESIGN (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.7
53人评分
我要评分
声誉 6.4 影响力 4.4 速度 8.5 | |||||||||||||||||||||
期刊ISSN | 1381-6128 | 微信扫码收藏此期刊 | ||||||||||||||||||||
E-ISSN | 1873-4286 | |||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.6 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:2.056 | |||||||||||||||||||||
2023-2024自引率 | 3.80%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 3 | |||||||||||||||||||||
JCI期刊引文指标 | 0.48 | |||||||||||||||||||||
h-index | 140 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | http://benthamscience.com/journal/index.php?journalID=cpd | |||||||||||||||||||||
期刊投稿网址 | http://benthamscience.com/journal/authors-guidelines.php?journalID=cpd#top | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CURRENT PHARMACEUTICAL DESIGN的语言要求,还能让CURRENT PHARMACEUTICAL DESIGN编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CURRENT PHARMACEUTICAL DESIGN编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR | |||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | |||||||||||||||||||||
涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Biweekly | |||||||||||||||||||||
出版年份 | 1995 | |||||||||||||||||||||
年文章数 | 276点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 1.34% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 35.87% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1381-6128%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2月 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 约25% | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在CURRENT PHARMACEUTICAL DESIGN顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy Author: Zhao, Binghao; Xiang, Zhongtian; Wu, Bo; Zhang, Xiang; Feng, Nan; Wei, Yiping; Zhang, Wenxiong Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 1, pp. 60-78. DOI: 10.2174/1381612829666221207112438 PubMed DOI |
2. | Exploration and Practice of Medicine Pathway for Perioperative VTE Prophylactic Anticoagulant Treatment Author: Zhang, Bin; Zhang, Chuanzhou; Li, Yongxin; Zhou, Changkai; Shi, Shiqiang; Ji, Hongyan; Li, Jing Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 251-255. DOI: 10.2174/1381612829666230112165449 PubMed DOI |
3. | Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/beta-catenin Signaling Pathway Author: Wang, Zhenkai; Liu, Xiang; Chen, Wanzhen; Guo, Xiujun; Chen, Lili; Wei, Zhiqin; Liu, Dan; Liu, Zheng Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 368-378. DOI: 10.2174/1381612829666230130141931 PubMed DOI |
4. | Network Pharmacology and Integrated Molecular Docking Study on the Mechanism of the Therapeutic Effect of Fangfeng Decoction in Osteoarthritis Author: Wang, Wenqiao; Li, Min; Si, Hongzong; Jiang, Zehui Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 5, pp. 379-392. DOI: 10.2174/1381612829666230216095659 PubMed DOI |
5. | Isorhynchophylline Regulates the Circadian Rhythm of the Hypothalamus in Spontaneously Hypertensive Rats to Treat Hypertension Author: Wang, Danyang; Sun, Mengjia; Liu, Yuecheng; Wang, Lihua; Li, Chao; Li, Yunlun; Jiang, Haiqiang Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 139-148. DOI: 10.2174/1381612829666221222115134 PubMed DOI |
6. | Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for In Vivo and In Vitro Sepsis Applications Author: Shi, Yi; Wu, Qian; Lu, Yi; Meng, Ling-Peng; Xu, Xiao-Ling; Wang, Xiao-Juan; Chen, Wei Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 283-294. DOI: 10.2174/1381612829666230201144029 PubMed DOI |
7. | Dysregulation of Angiopoietin-like-4 Associated with Hyperlipidemia-induced Renal Injury by AMPK/ACC Pathway Author: Qiu, WenHui; Huang, Luyang; Li, YueQiang; Liu, Qingquan; Lv, YongMan Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 300-309. DOI: 10.2174/1381612829666221219123937 PubMed DOI |
8. | Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease Author: Li, Lili; Zhang, Jiajia; Huang, Xiaoyue; Du, Jingguo; Tu, Zhiqiang; Wu, Haotian; Liu, Xu; Yuan, Mingqing Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 95-115. DOI: 10.2174/1381612829666221216114912 PubMed DOI |
9. | The Current Status of Antisense Gene Therapies for Bacteria-caused Diseases Challenges and Opportunities Author: Li, Jiawei; Liang, Xuejun; Wang, Fangxin; Wang, Juping; Ding, Feng Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 4, pp. 272-282. DOI: 10.2174/1381612829666230118152428 PubMed DOI |
10. | Soluble Urokinase Plasminogen Activator Receptor Contributes to ANCA-positive IgG-mediated Glomerular Endothelial Activation through TLR4 Pathway Author: Huang, Fei; Xu, Ranran; Wang, Yiru; Lv, Yongman; Liu, Qingquan Journal: CURRENT PHARMACEUTICAL DESIGN. 2023; Vol. 29, Issue 2, pp. 149-161. DOI: 10.2174/1381612829666221212094441 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室